The Board of Proteome Sciences plc announced that Abdel ghani Omarihas been appointed as the Company's new Chief Financial Officer. He will take up the position on September 1st, 2022 and will become a director of the Company. Abdel joins Proteome Sciences from Paion AG, a listed speciality pharmaceutical company, where he has been CFO and since 2014 a member of the management board.

During his time at Paion he has negotiated numerous license agreements with pharma companies and has raised more than EUR 150 million in financing from investors in the U.S. and in Europe. In addition to the finance role, Abdel was also responsible for HR, IT, Legal, IP & Compliance and more recently investor relations. Abdel has more than 20 years' experience in finance, starting his career at KPMG Audit after a business degree from the University of Aachen.

At KPMG he worked in audit and financial consultancy roles prior to joining Paion. Proteome Sciences' Chief Executive Officer, Dr. Mariola Soehngen, commented "The Board and the Company welcome Abdel as Proteome Sciences' CFO at this important point in the company's growth. Abdel brings a wealth of relevant experience to the team as pursue the Company´s strategy of organic growth, to grow the business through adding new high value services to portfolio and enter into further internationalization of the business.